The findings clarified the downregulation of LINC00173 and its chemosensitive role in DDP-resistant LUAD through a newly discovered pathway, indicating a potential clinical therapeutic target in LUAD, which was distinctly different from the role of LINC00173 in SCLC and LUSC. The gene discussed is LINC00173; the disease is small cell lung carcinoma.